Optimal Evaluation to Reduce Cardiovascular Imaging Testing
Recruiting
N/A
Interventional Study
Chronic Coronary Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 30 – 90
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 800 (estimated)
- Sponsor
- Tianjin Chest Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In daily clinical routine, the evaluation of new-onset and stable chest pain (SCP) suggestive of chronic coronary syndrome (CCS) remains a challenge for physicians. Although coronary computed tomography angiography (CCTA) seems to be the first-line cardiac imaging testing (CIT) according to the recommendations from current guidelines, the optimal diagnostic strategy to identify low risk patients w…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria
1. SCP or equivalenta suggestive of CCS and clinically stability
2. No history of CAD (prior myocardial infarction, CR or any CAD documented by previous CIT)
3. Age ≥30 years
4. Willing and able to provide informed consent
Exclusion criteria
1. Prior CIT within 1 year prior to …
Contacts